Particularly, we note that CRISP2 has the lowest correlation with immune cell infiltration, and there is almost no correlation result in the BPH group, suggesting that CRISP2 may be a diagnostic marker independent of the heterogeneity of immune cell infiltration. The gene discussed is CRISP2; the disease is benign prostatic hyperplasia.